Mocetinostat(MGCD0103),HDAC抑制剂

Mocetinostat (MGCD0103) (订货以英文为准)

编号:M126151
CAS号:726169-73-9
货号 品牌 包装 目录价 您的价格 库存 数量 购买
M126151-5mg 阿拉丁 5mg ¥599.90
M126151-50mg 阿拉丁 50mg ¥2471.90
M126151-25mg 阿拉丁 25mg ¥1338.90
259084-010 50mg ¥2471.90
259084-007 5mg ¥599.90
259084-008 25mg ¥1338.90
产品名称 Mocetinostat (MGCD0103)
中文名称 Mocetinostat(MGCD0103),HDAC抑制剂
CAS号 726169-73-9
储存条件 -20°C储存
溶解性DMSO 13 mg/mL (32.79 mM); Water <1 mg/mL (<1 mM); Ethanol <1 mg/mL (<1 mM)
存贮条件储存温度-20°C
应用A potent inhibitor of HDAC1, HDAC2, HDAC3, and HDAC11.
产品介绍Mocetinostat (MGCD0103)是一种有效的HDAC抑制剂,对HDAC1抑制作用最强,IC50为0.15 μM,比作用于HDAC2, 3,和11选择性高2到10倍,对HDAC4, 5, 6, 7,和8没有抑制活性。Phase 2。
备注Mocetinostat (MGCD0103) is a potent HDAC inhibitor with most potency for HDAC1 with IC50 of 0.15 μM, 2- to 10- fold selectivity against HDAC2, 3, and 11, and no activity to HDAC4, 5, 6, 7, and 8. Phase 1/2.
生化机理MGCD0103 potently inhibits a subset of the nine human recombinant HDACs, including HDAC1, HDAC2, HDAC3, and HDAC11. MGCD0103 reveals most potent inhibitory activity against human HDAC1 and HDAC2 enzymes in vitro, and it does not inhibit class II HDACs. The inhibitory activity of MGCD0103 reaches the maximum plateau at 6 μM, and the maximal inhibitable enzyme pool affected by MGCD0103 is 75% of the total enzyme activity in HCT116 cells.
别名N-(2-氨基苯基)-4-([[4-(吡啶-3-基)嘧啶-2-基]氨基]甲基)苯甲酰胺;MGCD0103;MGCD 0103;MGCD-0103;N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide
标识符号https://www.aladdin-e.com/images/ghs/ghs07.jpg
信号词Warning
危害声明H302-H312-H315-H317-H319-H332-H335
警示性声明P261-P280-P305 + P351 + P338
个人防护设备dust mask type N95 (US), Eyeshields, Faceshields, Gloves
RTECSMI5215000
WGK德国3
搜索质检报告(COA)
搜索MSDS
相关产品
CAS号:209783-80-2
¥ 279.90 E125068-10mg
CAS号:726169-73-9
¥ 599.90 M126151-5mg
CAS号:404950-80-7
¥ 139.90 P125167-10mg
CAS号:1310693-92-5
¥ 223.90 T129677-5mg
CAS号:149647-78-9
¥ 92.90 V125336-100mg
CAS号:112522-64-2
¥ 195.90 C126432-10mg
CAS号:1396841-57-8
¥ 294.90 R129686-5mg